Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
Infect Dis Poverty
; 7(1): 80, 2018 Aug 13.
Article
in En
| MEDLINE
| ID: mdl-30099967
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phosphorylcholine
/
Paromomycin
/
Amphotericin B
/
Leishmaniasis, Cutaneous
/
Pharmacovigilance
/
Leishmaniasis, Visceral
/
Antiprotozoal Agents
Type of study:
Etiology_studies
/
Guideline
/
Screening_studies
Aspects:
Patient_preference
Country/Region as subject:
Asia
Language:
En
Journal:
Infect Dis Poverty
Year:
2018
Document type:
Article
Affiliation country:
Bangladesh
Country of publication:
United kingdom